Baidu
map
BIOMARK MED 润色咨询

Biomarkers in Medicine

出版年份：2007 年文章数：1244 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-10-14 ms6000000169610742

    版面费一般多少嘞

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2018-10-23 WWW9450

    您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢obvious 2018-10-20 发表::
    接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。    obvious 2018-10-20 17:54:00 发表:
    三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。

    obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-09-05 ms3000000824250808

    审稿速度:6.0
    经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-08-05 小破孩er

    偏重的研究方向：肿瘤
    经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-08-24 ms6000000169610742

    偏重的研究方向：医学检验
    经验分享：请问版面费要多少呢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-12-16 yongshuang

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：肿瘤学;肿瘤
    经验分享：拒稿率高

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-09-29 shunyi1058

    投稿后迅速变为 Under Consideration

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-08-13 NANAxkj

    审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0
    偏重的研究方向：肿瘤学;临床检验
    经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2020-10-20 148a2525m13(暂无昵称)

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0
    偏重的研究方向：乳腺癌化疗耐药
    经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好，请问审稿流程有没有under review，还是under consideration就等同于under review啊，谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率：约50% 审稿时间：约1个月 三个月接收，当时是准备投future oncology的，提前给编辑写了封信，编辑让我转投他家的这个期刊，感觉有戏就投了。一审一个月，2个审稿人，提的问题都很简单。二审两个月，二审一直是under consideration状态????，所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享：投稿3个月零几天了，还是under consideration，好想知道其他人一审是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向：肿瘤<br>经验分享：请问有前辈分享投稿各个状态的时间吗，7.7投稿，现在还是under consideration。这是送审了吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向：医学检验<br>经验分享：请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤学;肿瘤<br>经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向：肿瘤学;临床检验<br>经验分享：食管癌方向偏临床的文章，审稿一个月给了个小修，修完以后一个月就直接接收了。总体来说还挺快的，版面费3500刀。需要注意的是，他们的系统在接收后没法直接看到proof的，要写编辑信才会有，编辑回信一般两天以内。投稿的时候没法选择共一和共通讯，只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向：乳腺癌化疗耐药<br>经验分享：10-12投一稿，10-20收到拒稿邮件，因为做的纯生信没加湿实验，拒稿理由缺少biological validation。没有经费做实验，没办法，不知道大家有推荐的低分期刊么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2019-06-28 hanbin0827_86788705

    人生第一次投稿，感觉好麻烦啊，身边的同学投稿流程就很简单，另外，我想问下通讯作者可以有几位？我再官网下载的文件中看到说是只能有一位通讯作者，可是我看到之前发过的文章有的有两位通讯作者，投稿才过了几天，是“under consideration”状态，看到大家说大概3个月接收，接收之后就是online了吗？见刊要几个月呢

    1

    展开1条回复
共57条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map